AIDS-related vacuolar myelopathy is not associated with coinfection by human T-lymphotropic virus type I.
Assessment of antibodies against human T-lymphotropic virus type I (HTLV-I) by enzyme-linked immunoassay, immunofluorescence, and Western blot was undertaken in patients with pathologically or clinically diagnosed acquired immunodeficiency syndrome-related vacuolar myelopathy to determine whether this retrovirus could be etiologically implicated in this disorder. No serological evidence for HTLV-I was found in the patients with vacuolar myelopathy, though 1 patient with an atypical myelopathy did have antibodies against HTLV-I.
Brew
B J
BJ
Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY.
Hardy
W
W
Zuckerman
E
E
Chien
N
N
Paul
M
M
Rosenblum
M
M
Gadler
H
H
Vahlne
A
A
Gold
J
J
Armstrong
D A
DA
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000276:immunology; D003711:Demyelinating Diseases / Q000209:etiology* / Q000276:immunology; D015481:HTLV-I Antibodies; D015490:HTLV-I Infections / Q000150:complications*; D006801:Humans; D013118:Spinal Cord Diseases / Q000209:etiology* / Q000276:immunology
D015481:HTLV-I Antibodies